HUP0002333A3 - Oligosaccharide mixtures having antithrombotic activity - Google Patents

Oligosaccharide mixtures having antithrombotic activity

Info

Publication number
HUP0002333A3
HUP0002333A3 HU0002333A HUP0002333A HUP0002333A3 HU P0002333 A3 HUP0002333 A3 HU P0002333A3 HU 0002333 A HU0002333 A HU 0002333A HU P0002333 A HUP0002333 A HU P0002333A HU P0002333 A3 HUP0002333 A3 HU P0002333A3
Authority
HU
Hungary
Prior art keywords
antithrombotic activity
oligosaccharide mixtures
oligosaccharide
mixtures
antithrombotic
Prior art date
Application number
HU0002333A
Other languages
English (en)
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10813494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002333(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of HUP0002333A2 publication Critical patent/HUP0002333A2/hu
Publication of HUP0002333A3 publication Critical patent/HUP0002333A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
HU0002333A 1997-06-03 1998-05-15 Oligosaccharide mixtures having antithrombotic activity HUP0002333A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711443.3A GB9711443D0 (en) 1997-06-03 1997-06-03 Chemical suppositions

Publications (2)

Publication Number Publication Date
HUP0002333A2 HUP0002333A2 (hu) 2000-12-28
HUP0002333A3 true HUP0002333A3 (en) 2002-01-28

Family

ID=10813494

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002333A HUP0002333A3 (en) 1997-06-03 1998-05-15 Oligosaccharide mixtures having antithrombotic activity

Country Status (20)

Country Link
US (1) US6486137B1 (hu)
EP (1) EP0986580B1 (hu)
JP (1) JP2002502454A (hu)
KR (1) KR20010013284A (hu)
CN (1) CN1145643C (hu)
AT (1) ATE236933T1 (hu)
AU (1) AU740671B2 (hu)
CA (1) CA2293587A1 (hu)
CZ (1) CZ292622B6 (hu)
DE (1) DE69813216T2 (hu)
DK (1) DK0986580T3 (hu)
ES (1) ES2193534T3 (hu)
GB (1) GB9711443D0 (hu)
HK (1) HK1028251A1 (hu)
HU (1) HUP0002333A3 (hu)
NZ (1) NZ501254A (hu)
PL (1) PL337231A1 (hu)
PT (1) PT986580E (hu)
RU (1) RU2216548C2 (hu)
WO (1) WO1998055514A1 (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4808997A (en) 1996-09-30 1998-04-24 Brigham And Women's Hospital Methods and compounds for treatment of abnormal uterine bleeding
JP2005505537A (ja) * 2001-08-28 2005-02-24 レオ・ファーマ・アクティーゼルスカブ 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
CN100345868C (zh) * 2003-04-18 2007-10-31 山东大学 一种低分子硫酸皮肤素及其制备方法
US20070219161A1 (en) * 2004-03-26 2007-09-20 Junichi Tamura Preparation Process Of Oligoglycosaminoglycan, And Reducing End Glucuronic Acid Type Oligochondroitin Sulfate And Pharmaceutical Composition Comprising The Same
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
KR101529061B1 (ko) * 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
ES2364683B1 (es) * 2009-12-29 2012-08-08 Bioibérica S.A. Disacáridos sulfatados para el tratamiento de enfermedades neurodegenerativas y/o neurovasculares.
WO2013006906A1 (en) * 2011-07-11 2013-01-17 Commonwealth Scientific And Industrial Research Organisation Dermatan sulphate, pharmaceutical compositions and process for producing same
WO2013095279A1 (en) 2011-12-19 2013-06-27 Dilafor Ab Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230582B (it) 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
IT1251182B (it) * 1991-08-28 1995-05-04 Opocrin Spa Oligosaccaridi di dermatan solfato, processo per la loro produzione e relative composizioni farmaceutiche.
IT1251183B (it) * 1991-08-28 1995-05-04 Opocrin Spa Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation

Also Published As

Publication number Publication date
EP0986580A1 (en) 2000-03-22
ES2193534T3 (es) 2003-11-01
RU2216548C2 (ru) 2003-11-20
NZ501254A (en) 2001-12-21
HUP0002333A2 (hu) 2000-12-28
DE69813216T2 (de) 2004-01-29
PT986580E (pt) 2003-08-29
ATE236933T1 (de) 2003-04-15
GB9711443D0 (en) 1997-07-30
CZ292622B6 (cs) 2003-11-12
CN1145643C (zh) 2004-04-14
CA2293587A1 (en) 1998-12-10
PL337231A1 (en) 2000-08-14
CZ431699A3 (cs) 2000-04-12
CN1259143A (zh) 2000-07-05
EP0986580B1 (en) 2003-04-09
AU7914698A (en) 1998-12-21
KR20010013284A (ko) 2001-02-26
US6486137B1 (en) 2002-11-26
WO1998055514A1 (en) 1998-12-10
DK0986580T3 (da) 2003-08-04
HK1028251A1 (en) 2001-02-09
AU740671B2 (en) 2001-11-08
DE69813216D1 (de) 2003-05-15
JP2002502454A (ja) 2002-01-22

Similar Documents

Publication Publication Date Title
IL133621A0 (en) Antithrombotic agents
IL133625A0 (en) Antithrombotic agents
ZA982050B (en) Sulfated oligosaccharides having anticoagulant/antithrom-botic activity
HK1028406A1 (en) Carbohydrate derivatives
HUP0002333A3 (en) Oligosaccharide mixtures having antithrombotic activity
GB9504331D0 (en) Antithrombotic agents
GB9416822D0 (en) Toilet
ZA951618B (en) Antithrombotic agents
GB9721363D0 (en) Dishwasher tablets
AU132188S (en) Dishwasher
EP1011666A4 (en) ANTITHROMBOTIC AGENTS
AU132449S (en) Dishwasher
EP0748333A4 (en) ANTITHROMBOTIC SUBSTANCES
EP0980367A4 (en) ANTITHROMBOTIC AGENTS
SI0986580T1 (en) Oligosaccharide mixtures having antithrombotic activity
EP0973517A4 (en) ANTITHROMBOTIC AGENTS
ZA951615B (en) Antithrombotic agents
EP0993300A4 (en) ANTITHROMBOTIC AGENTS
GB0005108D0 (en) Glucose responsive -cell line
KR0110041Y1 (en) Dishwasher
KR0109738Y1 (en) Dishwasher
KR970003430Y1 (en) Dishwasher
KR0109737Y1 (en) Dishwasher
KR0109736Y1 (en) Dishwasher
GB9422201D0 (en) Oligosaccharide preparation